pyrotinib for her2 breast cancer
Published 4 months ago • 23 plays • Length 21:03Download video MP4
Download video MP3
Similar videos
-
3:31
pyrotinib plus capecitabine for her2 metastatic breast cancer
-
1:29
poziotinib for her2-positive metastatic breast cancer
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
6:57
her2climb and nala trials: r/r her2 mbc
-
3:05
pi3k inhibitors for the treatment of brain metastases in her2-negative breast cancer
-
2:09
the evolution of her2 targeting in metastatic breast breast cancer
-
49:09
metastatic breast cancer forum 2018: her2-positive breast cancer | dana-farber cancer institute
-
1:37
dr. bhave on promising anti-her2 agents in her2 breast cancer
-
1:18
dr. pat whitworth on importance of the luminal subtype in breast cance
-
1:19
dr. pegram discusses the use of neratinib in her2 breast cancer
-
55:48
new & supporting data for optimizing therapy in her2 breast cancer | dr. bagegni & dr. gradishar
-
5:46
treating her2 mbc: immunotherapy and tkis
-
3:15
brain metastases in her2 breast cancer
-
1:27
dr. murthy on future of tucatinib in her2 breast cancer
-
0:58
dr. shao on prognosis of patients with her2 breast cancer
-
5:37
therapeutic landscape for patients with her2-positive breast cancer with active brain metastases
-
7:30
neratinib plus fulvestrant for her2 mutant, non-amplified metastatic breast cancer
-
1:07
dr. mitri on neratinib and pertuzumab in her2-amplified breast cancer